These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 13535490)

  • 1. [Hemagglutination by virus & its use in the demonstration of anti-influenza & anti-mumps viral antibiodies; tests on the antibody levels of population centers of Sardinia & Tuscany].
    PITZUS F
    Atti Accad Fisiocrit Siena Med Fis; 1957; 4():862-73. PubMed ID: 13535490
    [No Abstract]   [Full Text] [Related]  

  • 2. [Research on anti-influenza, anti-mumps & anti-Coxsackie antibodies in normal adults].
    GIOANNINI P; CAMARRI E; LOI ZEDDA P
    Boll Ist Sieroter Milan; 1957; 36(7-8):356-62. PubMed ID: 13471770
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies of anti-influenza and anti-parotitis antibodies in adult subjects of the province of Siena].
    LOI ZEDDA P
    Atti Accad Fisiocrit Siena Med Fis; 1956; 3():xxv-xxix. PubMed ID: 13445580
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modification of the receptivity of animal and human erythrocytes to influenza and mumps agglutinins after treatment of these erythrocytes with formol].
    FAUCONNIER B
    Ann Inst Pasteur (Paris); 1960 Jan; 98():107-11. PubMed ID: 13821706
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the effect of blood corpuscles on hemagglutination test with influenza and mumps virus].
    BRAND G; LIPPELT H; MULLER F
    Z Hyg Infektionskr; 1954; 139(4):293-304. PubMed ID: 13188136
    [No Abstract]   [Full Text] [Related]  

  • 6. A dialysable factor in the cerebrospinal fluid, fixing complement with formaldehyde.
    Wigand R; Go BS
    Z Immunitatsforsch Exp Klin Immunol; 1972 Sep; 144(2):217-9. PubMed ID: 4282940
    [No Abstract]   [Full Text] [Related]  

  • 7. The removal of nonspecific components from the soluble antigens of influenza and mumps viruses.
    POLLEY JR
    Can J Microbiol; 1957 Aug; 3(5):715-9. PubMed ID: 13460819
    [No Abstract]   [Full Text] [Related]  

  • 8. Single-chain intracellular antibodies inhibit influenza virus replication by disrupting interaction of proteins involved in viral replication and transcription.
    Mukhtar MM; Li S; Li W; Wan T; Mu Y; Wei W; Kang L; Rasool ST; Xiao Y; Zhu Y; Wu J
    Int J Biochem Cell Biol; 2009 Mar; 41(3):554-60. PubMed ID: 18687409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the effectiveness of anti-mumps vaccination by means of hemagglutination inhibition tests, using blood collected on filter paper disks].
    Copelovici Y; Strati I; Strulovici D; Mendel A; Băişan I
    Stud Cercet Inframicrobiol; 1967; 18(3):187-90. PubMed ID: 6078445
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of beta-propiolactone for the preparation of virus vaccines. I. Selection of reaction conditions.
    POLLEY JR; GUERIN MM
    Can J Microbiol; 1957 Oct; 3(6):863-70. PubMed ID: 13472511
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunity to influenza in older adults with chronic obstructive pulmonary disease.
    Gorse GJ; O'Connor TZ; Newman FK; Mandava MD; Mendelman PM; Wittes J; Peduzzi PN
    J Infect Dis; 2004 Jul; 190(1):11-9. PubMed ID: 15195238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative tests on hemagglutination inhibition with Newcastle virus and with mumps virus in sera of patients with epidemic parotitis].
    MONACI V
    Boll Ist Sieroter Milan; 1953; 32(7-8):276-9. PubMed ID: 13105837
    [No Abstract]   [Full Text] [Related]  

  • 13. A commercial ELISA detects high levels of human H5 antibody but cross-reacts with influenza A antibodies.
    Stelzer-Braid S; Wong B; Robertson P; Lynch GW; Laurie K; Shaw R; Barr I; Selleck PW; Baleriola C; Escott R; Katsoulotos G; Rawlinson WD
    J Clin Virol; 2008 Oct; 43(2):241-3. PubMed ID: 18675584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines: more reasons to immunize.
    Consum Rep; 2006 Oct; 71(10):62. PubMed ID: 16981311
    [No Abstract]   [Full Text] [Related]  

  • 15. Principles of vaccination and possible development strategies for rational design.
    Boog CJ
    Immunol Lett; 2009 Feb; 122(2):104-7. PubMed ID: 19100778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Discoveries of avian influenza A(H9N2) virus in chickens and men infected by H9N2 virus in Guangzhou area].
    Li CH; Zhou XZ; Li MX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):213-4. PubMed ID: 15640850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunogenicity and safety of domestic slit influenza vaccine].
    Zhu XJ; Zhang ZL; Li H; Su X; Guo XH; Chen W; Kou M; Duan WP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul; 25(7):644. PubMed ID: 15308057
    [No Abstract]   [Full Text] [Related]  

  • 18. Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma.
    Brydak LB; Machała M; Centkowski P; Warzocha K; Biliński P
    Vaccine; 2006 Nov; 24(44-46):6620-3. PubMed ID: 16870313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological survey of avian H5N2-subtype influenza virus infections in human populations.
    Yamazaki Y; Doy M; Okabe N; Yasui Y; Nakashima K; Fujieda T; Yamato S; Kawata Y; Ogata T
    Arch Virol; 2009; 154(3):421-7. PubMed ID: 19189196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mumps virus antihaemagglutinin values in cancer patients.
    LOGAN J
    N Z Med J; 1953 Oct; 52(291):400-2. PubMed ID: 13119931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.